Head and Neck Carcinoma — Research

Head and Neck Carcinoma — Research · CancerIndex

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

pubmedComputed3 windows · counts computed by CancerIndex from PubMed E-utilities; the exact query is stored with each count.

Window	Period	Records (count)	Exact query	Computed	Source
All time	… → 2026-09-11	7,796	`("Head and Neck Carcinoma"[tiab] OR "Carcinoma of Head and Neck"[tiab] OR "Carcinoma of the Head and Neck"[tiab])`	2026-09-11	pubmed
Last 5 years	2021-01-01 → 2026-12-31	1,439	`("Head and Neck Carcinoma"[tiab] OR "Carcinoma of Head and Neck"[tiab] OR "Carcinoma of the Head and Neck"[tiab]) AND (2021/01/01:2026/12/31[dp])`	2026-09-11	pubmed
Last 12 months	2025-09-11 → 2026-09-11	241	`("Head and Neck Carcinoma"[tiab] OR "Carcinoma of Head and Neck"[tiab] OR "Carcinoma of the Head and Neck"[tiab]) AND (2025/09/11:2026/09/11[dp])`	2026-09-11	pubmed

Data updated 20 days agoSource updated unknownsource: pubmed E-utilities

Literature

Linked publications (111)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedPublishedShowing 26–50 of 111 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer.
· J Clin Endocrinol Metab · 2005 · PMID 16174717 · validated civic_curation pubmed
A reappraisal of the MECT1/MAML2 translocation in salivary mucoepidermoid carcinomas.
· Am J Surg Pathol · 2010 · PMID 20588178 · validated civic_curation pubmed
Enhancer hijacking activates oncogenic transcription factor NR4A3 in acinic cell carcinomas of the salivary glands.
· Nat Commun · 2019 · PMID 30664630 · validated civic_curation pubmed
A minority of cases of acinic cell carcinoma of the salivary glands are driven by an NR4A2 rearrangement: the diagnostic utility of the assessment of NR4A2 and NR4A3 alterations in salivary gland tumors.